Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer (PARTIQoL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2015 by Massachusetts General Hospital
University of Pennsylvania
National Cancer Institute (NCI)
Central DuPage Hospital
M.D. Anderson Cancer Center
ProCure Proton Therapy Center
Washington University School of Medicine
Information provided by (Responsible Party):
Jason Efstathiou, Massachusetts General Hospital Identifier:
First received: June 8, 2012
Last updated: September 22, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)